Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasm, Residual × Clear all

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

35 enrolled

Breast

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Phase EARLY_PHASE1 Terminated

2 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04130152 2022-10-25

PROMETEO II

Phase EARLY_PHASE1 Completed

22 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual

Clinical Trials

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

PROMETEO II